Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis

SUMMARY: Monthly minodronate at 30 or 50 mg had similar efficacy as 1 mg daily in terms of change in bone mineral density (BMD) and bone turnover markers with similar safety profiles. This new regimen provides patients with a new option for taking minodronate. INTRODUCTION: Minodronate at a daily or...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Okazaki, R., Hagino, H., Ito, M., Sone, T., Nakamura, T., Mizunuma, H., Fukunaga, M., Shiraki, M., Nishizawa, Y., Ohashi, Y., Matsumoto, T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer-Verlag 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353114/
https://ncbi.nlm.nih.gov/pubmed/21932114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-011-1782-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky